Abstract:Arsenic is a well-known human carcinogen, which potentially affects ~160 million people worldwide via exposure to unsafe levels in drinking water. Lungs are one of the main target organs for arsenic-related carcinogenesis. These tumors exhibit particular features, such as squamous cell-type specificity and high incidence among never smokers. Arsenic-induced malignant transformation is mainly related to the biotransformation process intended for the metabolic clearing of the carcinogen, which results in specifi… Show more
“…In North America lung cancer, is one of the leading causes of mortality. Arsenic's capability of inducing specific alterations into pathways that regulate tumor formation in lung cells has been elucidated by Hubaux and colleagues (Hubaux et al, 2013) (Figure 14). Increased exposure of arsenic concomitantly increased the susceptibility of lung cancer both in smokers and non-smokers (Järup and Pershagen, 1991).…”
Section: Lungsmentioning
confidence: 97%
“…Various studies showed the susceptibility of human lungs towards arsenic consumption (Celik et al, 2008;Gibb et al, 2011;Guha Mazumder, 2007) and managed to setup a link between ingestion of iAs through drinking water and human lung cancer development (Ferreccio et al, 2000). Nevertheless, lungs are one of the major targets for tumorigenesis due to arsenic exposure (Hubaux et al, 2013). High mortality rate of patients due to lung cancer has been reported (Hopenhayn-Rich et al, 1998;Lamm et al, 2013;Smith et al, 2012b).…”
“…In North America lung cancer, is one of the leading causes of mortality. Arsenic's capability of inducing specific alterations into pathways that regulate tumor formation in lung cells has been elucidated by Hubaux and colleagues (Hubaux et al, 2013) (Figure 14). Increased exposure of arsenic concomitantly increased the susceptibility of lung cancer both in smokers and non-smokers (Järup and Pershagen, 1991).…”
Section: Lungsmentioning
confidence: 97%
“…Various studies showed the susceptibility of human lungs towards arsenic consumption (Celik et al, 2008;Gibb et al, 2011;Guha Mazumder, 2007) and managed to setup a link between ingestion of iAs through drinking water and human lung cancer development (Ferreccio et al, 2000). Nevertheless, lungs are one of the major targets for tumorigenesis due to arsenic exposure (Hubaux et al, 2013). High mortality rate of patients due to lung cancer has been reported (Hopenhayn-Rich et al, 1998;Lamm et al, 2013;Smith et al, 2012b).…”
“…However, recent studies have shown that arsenosugars, the major arsenical constituent of marine algae [9], can be easily metabolised by humans into a multitude of arsenic metabolites, including dimethylarsinic acid (DMA) and its sulphur analogue, thio-DMA, which have been extensively toxicologically characterised [10,11]. Considerable progress has been made in recent years to address arsenic toxicity, including both genetic and epigenetic alteration [12,13]. In spite of these efforts, the putative mechanism underlying arsenic toxicity remains vague given the complicated metabolism of arsenic in the human body, and no effective treatment for arsenicosis exists [3].…”
“…In the same period, the Antofagasta region (North of Chile), historically exposed to high levels of drinking water Arsenic (dw-As), showed a mortality rate of 31.6 for both genders, with a rate of 44.2 and 17.4, for men and women, respectively [4][5][6][7][8]. The implementation of earlydetection technologies and prognostic biomarkers are imperative, specifically in cities highly exposed to environmental carcinogens, such as PAHs and Arsenic [9][10][11][12][13]. It is extremely important to have complementary and noninvasive tools, to apply in asymptomatic population, especially to individuals with high risk of LC.…”
The implementation of early-detection technologies and prognostic biomarkers are imperative, specifically in cities highly exposed to environmental carcinogens, such as PAHs and Arsenic. This study proposed to evaluate cfDNA levels and determine CNAs in serum cfDNA in LC and PNL patients. The study enrolled a total of 107 people, from the Metropolitan (N=51) and Antofagasta (N=56) regions, with medium or high LC risk. The cfDNA was isolated from serum aliquots using Qiagen QIAamp DNA mini kit. HMMs analysis in cfDNA, was used as a probabilistic model to determine an unknown sequence and defined Minimal Common Regions (MCRs) of recurring DNA gains and losses. This study shows that cfDNA levels increased during malignancy of LC but not significantly during premalignant lesions or pre-invasive stages. The cfDNA could be used as a complementary tool to prognosis and evolution of LC, with high precision (specificity of 87.3% and PNV of 76.4%). Additionally, the cfDNA carry some chromosomal aberrations related with the lung tumorigenesis process that could be used to confirm a suspected case of LC. Within these alterations our results suggest the loss of specific chromosomic fragments, contain genes related with inflammation response (SERPING1), humoral immune response (IGCK), innate immunity and epithelial integrity (CTNN1), tumor suppressor (MAP2K4, DMTF1 and ABCB4), and response to oxidative stress (COX10). In conclusion, these biomarkers in cfDNA, could have a great potential as screening methods in population with high risk for LC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.